Hugo Katus
Chairman of Scientific Advisory Board and Managing Director of UniQure-GermanyProf. Hugo Katus is Co-Founder and Chief Medical Officer of AaviGen GmbH. Prof. Katus is a distinguished figure in cardiology renowned for inventing the Troponin T test, the gold standard in acute myocardial infarction (MI) diagnostics. With a medical degree from the University of Heidelberg, Germany and postdoctoral studies at Harvard Medical School, he possesses a wealth of knowledge in cardiovascular medicine. As Director of Cardiology at the University of Heidelberg, Prof. Katus spearheaded groundbreaking research and mentored a new generation of cardiologists. His research spans molecular mechanisms of heart failure, genetic determinants of cardiovascular diseases and advanced diagnostic tools. With a compassionate approach to patient care, Prof. Katus has significantly impacted the field. His leadership and expertise continue to shape the future of cardiovascular medicine, making him a luminary in the field. Prof. Katus has been the Chairman of Scientific Advisory Board at uniQure N.V. since August 2014.
Positions
- Company NameuniQure N.V.Stock CodeQUREPositionChairman of Scientific Advisory Board and Managing Director of UniQure-GermanyColleagues
- MCMatthew Craig KapustaCEO & Executive Director
- DDDavid D. MeekIndependent Chairman of the Board
- CKChristian KlemtCFO, Principal Financial Officer & GM of Amsterdam Site
- JPJeannette PottsChief Legal & Compliance Officer and Corporate Secretary
- WAWalid Abi-SaabChief Medical Officer
- JLJack L. KayeIndependent Non-Executive Director
- MBMadhavan BalachandranIndependent Non-Executive Director
